Braasch Biotech

Braasch Biotech LLC is a privately held, pre-clinical stage vaccine company dedicated to the discovery, early development, and commercialization of exciting new biopharmaceutical vaccine products for both human and animal health markets. Braasch's patented and patent-pending technology is a leading choice for the treatment of human obesity.In the agricultural sector, vaccines that ensure safety and enhance productivity without the use of antibiotics, drugs, or hormones have been embraced by global industry leaders as a novel approach with significant market value.